Loading clinical trials...
Loading clinical trials...
Open Randomized Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: TENOFOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC
Conditions
Interventions
Tenofovir, emtricitabine, maraviroc
Tenofovir, emtricitabine, lopinavir/r
Locations
1
Spain
Hospital Clinic de Barcelona
Barcelona, Barcelona, Spain
Start Date
February 1, 2012
Primary Completion Date
June 1, 2014
Completion Date
June 1, 2014
Last Updated
April 1, 2015
NCT04929028
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT06665646
Lead Sponsor
Hospital Clinic of Barcelona
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions